Global Waterfowl Vaccines Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Waterfowl Vaccines Market Insights, Forecast to 2034
Waterfowl vaccine is a vaccine specially developed for waterfowl (such as ducks, geese, etc.). It is designed to prevent and control common infectious diseases of waterfowl to protect their health and improve the production efficiency of the breeding industry.
Global Waterfowl Vaccines market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Waterfowl Vaccines industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Waterfowl Vaccines key manufacturers include Sanofi Pasteur, Merck Animal Health, Zoetis, China Animal Husbandry Industry Co.,Ltd., Tianjin Ringpu Bio-technology Co.,Ltd., Harbin Pharmaceutical Group Bio-Vaccine Co.,Ltd, Ceva Santé Animale, Boehringer Ingelheim and Institute of Animal Health and Veterinary Biologicals, etc. Sanofi Pasteur, Merck Animal Health, Zoetis are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Waterfowl Vaccines were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Waterfowl Vaccines market and estimated to attract more attentions from industry insiders and investors.
Waterfowl Vaccines can be divided into Newcastle Disease Vaccine, Duck Cholera Vaccine, Bird Flu Vaccine and Duck Pullorum Vaccine, etc. Newcastle Disease Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Waterfowl Vaccines is widely used in various fields, such as Breeding Farm, Domestic Waterfowl Breeding, Zoo and Research and Education, etc. Breeding Farm provides greatest supports to the Waterfowl Vaccines industry development. In 2022, global % sales of Waterfowl Vaccines went into Breeding Farm filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Waterfowl Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Waterfowl Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

Sanofi Pasteur
Merck Animal Health
Zoetis
China Animal Husbandry Industry Co.,Ltd.
Tianjin Ringpu Bio-technology Co.,Ltd.
Harbin Pharmaceutical Group Bio-Vaccine Co.,Ltd
Ceva Santé Animale
Boehringer Ingelheim
Institute of Animal Health and Veterinary Biologicals
Qilu Pharmaceutical Co., Ltd.
CZ Vaccines
Bio Veta
Qilu Animal Health Products Factory
Veterinary Serum and Vaccine Research Institute
Jofunhwa Biotechnology (Nanjing) Co., Ltd.
Segment by Type
Newcastle Disease Vaccine
Duck Cholera Vaccine
Bird Flu Vaccine
Duck Pullorum Vaccine
Others
Breeding Farm
Domestic Waterfowl Breeding
Zoo
Research and Education
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Waterfowl Vaccines plant distribution, commercial date of Waterfowl Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Waterfowl Vaccines introduction, etc. Waterfowl Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Waterfowl Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Waterfowl Vaccines market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Waterfowl Vaccines industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Waterfowl Vaccines key manufacturers include Sanofi Pasteur, Merck Animal Health, Zoetis, China Animal Husbandry Industry Co.,Ltd., Tianjin Ringpu Bio-technology Co.,Ltd., Harbin Pharmaceutical Group Bio-Vaccine Co.,Ltd, Ceva Santé Animale, Boehringer Ingelheim and Institute of Animal Health and Veterinary Biologicals, etc. Sanofi Pasteur, Merck Animal Health, Zoetis are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Waterfowl Vaccines were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Waterfowl Vaccines market and estimated to attract more attentions from industry insiders and investors.
Waterfowl Vaccines can be divided into Newcastle Disease Vaccine, Duck Cholera Vaccine, Bird Flu Vaccine and Duck Pullorum Vaccine, etc. Newcastle Disease Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Waterfowl Vaccines is widely used in various fields, such as Breeding Farm, Domestic Waterfowl Breeding, Zoo and Research and Education, etc. Breeding Farm provides greatest supports to the Waterfowl Vaccines industry development. In 2022, global % sales of Waterfowl Vaccines went into Breeding Farm filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Waterfowl Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Waterfowl Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Sanofi Pasteur
Merck Animal Health
Zoetis
China Animal Husbandry Industry Co.,Ltd.
Tianjin Ringpu Bio-technology Co.,Ltd.
Harbin Pharmaceutical Group Bio-Vaccine Co.,Ltd
Ceva Santé Animale
Boehringer Ingelheim
Institute of Animal Health and Veterinary Biologicals
Qilu Pharmaceutical Co., Ltd.
CZ Vaccines
Bio Veta
Qilu Animal Health Products Factory
Veterinary Serum and Vaccine Research Institute
Jofunhwa Biotechnology (Nanjing) Co., Ltd.
Segment by Type
Newcastle Disease Vaccine
Duck Cholera Vaccine
Bird Flu Vaccine
Duck Pullorum Vaccine
Others
Segment by Application
Breeding Farm
Domestic Waterfowl Breeding
Zoo
Research and Education
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Waterfowl Vaccines plant distribution, commercial date of Waterfowl Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Waterfowl Vaccines introduction, etc. Waterfowl Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Waterfowl Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
